Bloodline Reviews 3-2, Immuno-fine-tuning: Focus on Intravenous Immune Globulin Selection
 |
Pharmaceutical Aspects of IVIG Jerry Siegel, RPh, FASHP - Session Chair Senior Director, Pharmaceutical Services Clinical Associate Professor The Ohio State University Medical Center College of Pharmacy Columbus, Ohio The Cost of Adverse Events: How to Prevent and Treat Thomas G. Schleis, MS, RPh Director of Pharmacy Northwest Medical Specialties Tacoma,Washington Expanding Use of IGIV: New Concepts and a Requirement for an Integrated Team Approach Erwin W. Gelfand, MD Chairman, Department of Pediatrics Professor of Pediatrics and Immunology National Jewish Medical and Research Center University of Colorado Health Sciences Center Denver, Colorado Questions & Answers |
Copyright © 1995-2008